EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 97 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $199,393 | -70.7% | 168,977 | +205.1% | 0.00% | -80.0% |
| Q4 2020 | $681,000 | +508.0% | 55,389 | +302.8% | 0.01% | +150.0% |
| Q3 2020 | $112,000 | -60.6% | 13,751 | -67.0% | 0.00% | -71.4% |
| Q1 2020 | $284,000 | -84.8% | 41,714 | -66.7% | 0.01% | -36.4% |
| Q4 2019 | $1,866,000 | +55.2% | 125,220 | +6.8% | 0.01% | 0.0% |
| Q3 2019 | $1,202,000 | -7.5% | 117,250 | -4.3% | 0.01% | -15.4% |
| Q2 2019 | $1,299,000 | +89.1% | 122,569 | +149.4% | 0.01% | +85.7% |
| Q1 2019 | $687,000 | +84.7% | 49,141 | +34.1% | 0.01% | +75.0% |
| Q4 2018 | $372,000 | +204.9% | 36,647 | +259.3% | 0.00% | +300.0% |
| Q3 2018 | $122,000 | – | 10,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Simplify Asset Management Inc. | 2,700,000 | $823,500 | 0.09% |
| 683 Capital Management, LLC | 2,650,000 | $808,250 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 355,867 | $109 | 0.01% |
| RBF Capital, LLC | 391,265 | $119,336 | 0.01% |
| UBS OCONNOR LLC | 393,975 | $120,162 | 0.00% |
| XTX Topco Ltd | 15,597 | $4,757 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 106,700 | $32,544 | 0.00% |
| AMERIPRISE FINANCIAL INC | 8,592,471 | $2,620,704 | 0.00% |
| DRW Securities, LLC | 120,365 | $37 | 0.00% |
| DFPG INVESTMENTS, LLC | 32,430 | $10,896 | 0.00% |